Rimac Seguros Faces Valuation Shift Amid Declining Financial Performance and Market Challenges
Rimac Seguros y Reaseguros has experienced a recent evaluation adjustment, highlighting changes in its financial metrics and market standing. Key indicators show a P/E ratio of 5 and a price-to-book value of 0.72, while the company faces challenges with declining net sales and operating profits.
Rimac Seguros y Reaseguros has recently undergone an adjustment in its evaluation, reflecting notable shifts in its financial metrics and market position. The company's valuation grade has been revised, indicating a change in its perceived worth within the insurance industry. Key financial indicators reveal a P/E ratio of 5 and a price-to-book value of 0.72, suggesting a distinct valuation landscape compared to industry peers.The company's performance has been characterized by a negative trajectory in operating profits, with a reported annual growth rate of 0.00%. Recent results have shown a decline in net sales, which totaled PEN 3,379.55 million, marking a significant drop of 52.71%. Additionally, the return on capital employed (ROCE) has reached a low of 14.21%, further emphasizing the challenges faced by the company.
On the technical side, trends have shifted from bearish to mildly bullish, with indicators such as the MACD and moving averages reflecting a more favorable outlook in the short term. However, the overall long-term fundamental strength remains weak, as evidenced by consecutive quarters of negative results.
For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read
